Claire

What is Claire and who sells it?

Fawkes Biodata Inc. is based in Toronto, Ontario, and its about page says the company was founded in 2026. Dr. Ian Taylor is CEO and co-founder, described there as Harvard Medical School-trained with a PhD in AI for medicine (clairemed.ai/about). Funding, customer counts and the rest of the team are not published.

What does it do?

Before the appointment Claire interviews the patient by phone, in more than 40 languages according to the vendor's site. It organizes the history and prepares the SOAP note. The vendor also lists defined appointment workflows and supported clinician forms such as WSIB and immunization.

Clinician messages, prescriptions, referrals and post-visit follow-up are marked in development on the homepage. No paper on the product is indexed in PubMed.

The vendor's FAQ says physicians in its survey reported connecting "in under one minute" and receiving a drafted SOAP note "in under three minutes from the end of intake". Sample size and method are not given (clairemed.ai/faq).

What does the vendor say about privacy and integration?

The homepage says Claire is "designed to support HIPAA, PHIPA and PIPEDA requirements", which states intent and is no certification. The privacy page says a BAA is signed with every practice before PHI is handled, hosting is on Google Cloud Platform under a BAA, and data is protected by TLS in transit, encryption at rest, MFA and access logging. Data residency is available on request (clairemed.ai/privacy-compliance).

SOC 2, HITRUST and ISO 27001 are not stated on the site, the AI model provider is not named, and audio retention is not addressed. Claire is described as EMR-agnostic and designed to work alongside the clinic's existing system. No EHR is named, and a Chrome extension called Claire-Note is mentioned.

What does Claire cost?

The pricing page (November 2026) shows $499 USD per provider per month, or $4,999 per provider per year charged once, which works out to about $417 a month. Trial, refund and discount terms are not stated.

How does the vendor place it against other tools?

The comparison pages on clairemed.ai set Claire against Freed, Heidi (Accuro AI Scribe), Mika AI and Prosper. In them the vendor concedes that Mika AI is stronger for clinics that want one vendor for scribing, booking and direct Canadian EMR integrations, and that Freed is simpler for solo primary care (clairemed.ai/claire-vs-freed, vendor-authored).

The verdict

Claire is a pre-visit intake product with a physician-owned draft at the end, and a company founded in 2026. The site names no EHR, no model provider and no SOC 2 report, and the only timing figures are from the vendor's own survey. A physician who wants a recorder running during the visit needs a different product, and one who wants the history done by phone beforehand is the buyer the product describes.